The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent

Cited by papers we hold 4

• Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier · 2022
  No notice
• Cancer combination therapies by angiogenesis inhibitors; a comprehensive review · 2022
  No notice
• Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons · 2022
  No notice
• Mechanisms of immune evasion in bladder cancer · 2019
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.